HPX / Hemopexin · Western blot design guide

Design a Western Blot for HPX

Real validated HPX Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-HPX WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for HPX: expected band ~51.7 kDa, hero antibody A02237-2, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable HPX Western blot protocol sheet — expected band ~51.7 kDa, antibody A02237-2, controls and PMC citations. Open the full HPX WB guide →

HPX Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~51.7 kDa
Observed band ≈72 kDa
Gel 5–20% (catalog A02237-2)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Glycosylated + Cleaved
Caveat Glycosylation-state controls
Gene-set association MSigDB C7 membership
Isoform 1 isoform(s)
Section 1

Real Curated HPX Western Blot Protocols

The A02237-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman HepG2, human HCCT, human HCCP (catalog A02237-2)
Gel %5–20% (catalog A02237-2)
Load30 ug; reducing conditions (catalog A02237-2)
Transfera nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A02237-2)
Membranenitrocellulose membrane (catalog A02237-2)
Blocking5% non-fat milk/TBS for 1.5 hour at RT (catalog A02237-2)
Primary antibodyA02237-2 · 0.5 μg/mL (catalog A02237-2)
Primary incubationovernight at 4°C (catalog A02237-2)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000 (catalog A02237-2)
Secondary incubation1.5 hour at RT (catalog A02237-2)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog A02237-2)
DetectionECL (catalog A02237-2)
Section 2

What Is the Expected HPX Western Blot Band Size?

HPX is predicted at 51.7 kDa and observed near 72 kDa; the cause of that difference is not established by the supplied evidence.

What am I looking at on my blot?
Band near 72 kDaEmpirical HPX band in reducing lysate blots; confirm identity with appropriate controls.
Band near 51.7 kDaNear the predicted full-length precursor mass; identity requires confirmation.
Band slightly below precursorMay reflect cleavage of the 1–23 signal peptide; the migration change is unmeasured.
Little or no lysate bandHPX is secreted, so it may be more abundant outside cells.
Broad band around 72 kDaGlycoform variation is possible, but the listed sites do not establish a smear.
💡Expected HPX appearanceHPX has a predicted full-length mass of 51.7 kDa and an empirical band near 72 kDa; the cause of the difference is unestablished, so confirm band identity with appropriate controls.
How each factor affects band size
Predicted full-length mass51.7 kDa is the sequence-based precursor mass; reducing lysate blots show a band near 72 kDa, with the difference unexplained.
Signal peptide at residues 1–23Cleavage makes mature HPX smaller than its precursor; the migration change is unmeasured.
O-linked glycosylation at Thr24 and Thr29May affect apparent migration; its contribution to the 72 kDa band is unmeasured.
Complex N-linked glycosylation at Asn64, Asn187 and Asn453May affect apparent migration; the size effect is unmeasured.
N-linked glycosylation at Asn240 and Asn246May affect apparent migration; the size effect is unmeasured.
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateSecreted HPX may be scarce in the cell fraction.Check conditioned medium alongside a positive lysate control.
Band higher than expectedThe empirical HPX band is near 72 kDa, above the 51.7 kDa predicted precursor mass; the cause is unestablished.Compare with a validated HPX positive control and test band identity by HPX depletion.
Band lower than expectedSignal-peptide cleavage can reduce mass, but a large shift has no established explanation here.Compare precursor and mature samples and confirm the band with HPX depletion.
Broad smear instead of sharp bandVariation among glycosylated HPX molecules is possible but unproven.Compare untreated and deglycosylated aliquots with an HPX positive control.
Multiple bandsGlycosylation or signal-peptide processing may contribute, but distinct bands are not established.Compare with a positive control and check which bands disappear after HPX depletion.
Weak or no signalSecreted HPX may be low in the tested fraction.Test conditioned medium and a validated positive control.

Sample controls for HPX Western blot

🧪For positive controls for HPX in Western blot, you can use an HPA-positive sample once one is identified; no positive tissue or cell is supplied.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside.
⚠️Feasibility: HPX is secreted, so whole-cell lysate may give little signal; consider conditioned medium.

HPA tissue expression evidence for HPX

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced HPX Western Blot Tips

Deeper troubleshooting and optimisation questions for HPX, answered from its protein features.

How should HPX band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Do annotated HPX isoforms explain multiple bands?
Isoforms · The supplied record lists one isoform and no alternative sequence. It therefore provides no annotated isoform basis for assigning a second band. Assess additional bands using the documented processing and glycosylation features without identifying their cause from size alone.
Which HPX glycosylation sites matter when interpreting bands?
PTM · UniProt lists O-linked threonines at 24 and 29 and N-linked asparagines at 64, 187, 240, 246 and 453. These are UniProt sequence coordinates. Glycosylation may affect migration, but the site list does not establish a specific band shift.
Does this guide establish induction of HPX?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for HPX?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A02237-2 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How can I quantify the HPX band consistently?
Quantitation · Use the same sample preparation and band selection across the samples being compared. HPX is secreted and has annotated glycosylation and disulfide bonds, so document the sample fraction and reducing conditions. The supplied features do not establish that every HPX-containing band has the same identity.
Why is HPX observed near 72 kDa rather than 51.7 kDa?
Interpretation · The 51.7 kDa prediction is based on the protein sequence, while approximately 72 kDa is the supplied apparent Western blot band. HPX has a signal peptide at residues 1–23 and seven annotated glycosylation sites. These features are relevant when interpreting migration, but the annotations alone do not establish the cause or size of the observed difference.

HPX has an annotated signal peptide at residues 1–23 and is secreted. The 51.7 kDa predicted mass refers to the supplied full sequence; signal peptide processing is relevant when comparing it with a mature protein band. The supplied features do not specify the processed protein’s measured mass.

HPX is annotated as secreted, so a sample’s extracellular fraction is relevant when planning detection. Its signal peptide spans residues 1–23. The supplied features do not establish how much HPX will be present in any particular sample.

UniProt annotates six disulfide bonds in HPX. Compare reducing and nonreducing preparations if migration differs between protocols, and keep preparation conditions consistent across lanes. The annotation does not predict a particular band pattern or shift.

Compare them with the approximately 72 kDa observed band and check whether sample preparation differs. HPX has a signal peptide, seven glycosylation sites and six disulfide bonds, all relevant to interpretation. The supplied features do not identify any particular additional band.
Boster reagents

HPX Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of Hemopexin/HPX using anti-Hemopexin/HPX antibody (A02237-2). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human HepG2 whole cell lysates, Lane 2: human HCCT tissue lysates, Lane 3: human HCCP tissue lysates, Lane 4: human placenta tissue lysates, Lane 5: rat liver tissue lysates, Lane 6: rat RH35 whole cell lysates, Lane 7: mouse liver tissue lysates, Lane 8: mouse HEPA1-6 whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-Hemopexin/HPX antigen affinity purified polyclonal antibody (Catalog # A02237-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for Hemopexin/HPX at approximately 72 kDa. The expected band size for Hemopexin/HPX is at 72 kDa.
Anti-Hemopexin/HPX Antibody Picoband®
Cat # A02237-2
Real WB data Western blot analysis of Hemopexin/HPX using anti-Hemopexin/HPX antibody (M02237). Electrophoresis was performed on a 10% SDS-PAGE gel at 80V (Stacking gel) / 120V (Resolving gel) for 2 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human HepG2 whole cell lysates, Lane 2: human Caco-2 whole cell lysates, Lane 3: human hepatocellular carcinoma tumor tissue (HCCT) lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-Hemopexin/HPX antigen affinity purified monoclonal antibody (M02237) at 1:1000 overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an ECL Plus Western Blotting Substrate (Catalog # AR1196-200) with Tanon 5200 system. A specific band was detected for Hemopexin/HPX at approximately 70 kDa. The expected band size for Hemopexin/HPX is at 52 kDa.
Anti-Hemopexin HPX Monoclonal Antibody
Cat # M02237

Both listed anti-HPX antibodies have Western blot images. A02237-2 shows an approximately 72 kDa band in human, rat, and mouse samples, matching its stated expected size. M02237 shows an approximately 70 kDa band in human samples, versus a stated expected size of 52 kDa.

Which to pick: Choose A02237-2 for human, mouse, or rat samples based on the reported reactivity and illustrated lanes. M02237 is listed for human samples only; its illustrated human lanes show a band at 70 kDa, so consider the discrepancy from its stated 52 kDa expectation.

Source: BosterBio HPX gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.